ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,635, issued on March 24, was assigned to Biomed Valley Discoveries Inc. (Kansas City, Mo.).

"Compositions and methods for treating cancer with atypical BRAF mutations" was invented by Gary DeCrescenzo (Parkville, Mo.), Dean Welsch (Parkville, Mo.) and Saurabh Saha (Wellesley Hills, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, inter alia, methods, pharmaceutical compositions, and kits for treating or ameliorating the effects of a cancer in a subject, which harbors an atypical BRAF mutation (i.e. a non-V600E/K BRAF mutation), comprising an ERK inhibitor. Also provided are methods for identifying a subject havin...